Lactadherin, known for its anti-inflammatory properties within the CNS, looks like a very promising biomarker for CAA as it was correlated with CSF levels of Aβ 40 and Aβ 42 and could differentiate CAA from AD and controls. The gene discussed is MFGE8; the disease is Alzheimer disease.